Clinical Trial Update: Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial comparing Buparid/PARI SINUS to Budes nasal spray in chronic rhinosinusitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis
• Sinusitis

Drugs mentioned

• Budes nasal spray
• Buparid/PARI SINUS

Snippet

Sponsor: Pari Pharma GmbH | Conditions: Rhinosinusitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-04-12